Get the content you want anytime you want.
REGISTER NOW | SIGN IN

The Contagion® Healthcare Associated Infections (HAI) specialty page provides HAI-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HEALTHCARE-ASSOCIATED INFECTIONS (HAI) VIDEOS - Page 1

<i>Pseudomonas</i> Infections: Prognoses & Treatment Approaches
Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; Andrew Shorr, MD; Marin Hristos Kollef, MD; and Yoav Golan, MD, reflect on the impact that Pseudomonas infections have on patients’ prognoses and outline the basic treatment approaches they take to combat these infections.
Gram-Positive NIs: Nuancing Lipoglycopeptide Therapy
Peter L. Salgo, MD; Sandy J. Estrada Lopez, PharmD, BCPS (AQID); Jason Pogue, PharmD, BCPS-AQID; Andrew Shorr, MD; and Debra Goff, PharmD, FCCP, reflect on the caveats in lipoglycopeptide therapy for gram-positive nosocomial infections and emphasize that this is a different, not overarchingly effective, class of drugs.
<i>Pseudomonas</i> Infections: Matching Causes and Prevention
Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; Marin Hristos Kollef, MD; Andrew Shorr, MD; and Yoav Golan, MD, differentiate between pseudomonas colonization and infection, discussing important prevention methods regarding the causes of affliction.
<i>Pseudomonas</i> Infections in the ICU: Who's Susceptible?
Peter L. Salgo, MD; Marin Hristos Kollef, MD; Jason Pogue, PharmD, BCPS-AQID; Yoav Golan, MD; and Andrew Shorr, MD, identify which patients are most susceptible to Pseudomonas infections and address the settings in which risk for infection is greatest.
<i>C. difficile</i> Rates in the United Kingdom
Dr. Richard Vickers, discusses C. difficile rates in the United Kingdom.
Fecal Transplantation in <i>Clostridium difficile</i>
Lawrence J. Brandt, MD; Erik Dubberke, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, consider variables surrounding the use of fecal transplantation for the management of Clostridium difficile in select groups of patients.
Incorporating Technology into Antimicrobial Stewardship Programs
Debra Goff, PharmD, FCCP, explains how technology can be incorporated into antimicrobial stewardship programs.
Gram-Negative Nosocomial Infections: Systemic Risk
Peter L. Salgo, MD; Andrew Shorr, MD; Jason Pogue, PharmD, BCPS-AQID; Sandy J. Estrada Lopez, PharmD, BCPS (AQID); and Debra Goff, PharmD, FCCP, share insight on risk factors and systemic issues associated with long-term care settings that contribute to the formation of gram-negative nosocomial infections.